When Microsoft AI announced one of its systems solved complex medical cases more accurately and cost-effectively than expert physicians, the company touted the results as a first step on the “path to medical superintelligence.”
Health care leaders with whom Healio spoke expressed more muted enthusiasm. They commended how the company evaluated the technology and acknowledged its potential to guide decision-making, but they emphasized the data are preliminary and require rigorous validation.
“The approach they took is pretty genius, and I think this holds a lot of promise as a